Selective laser sintering 3D printing – an overview of the technology and pharmaceutical applications

Volume: 46, Issue: 6, Pages: 869 - 877
Published: May 13, 2020
Abstract
Food and Drug Administration (FDA) has approved a drug product (Spritam®) and many medical devices manufactured by three-dimensional printing (3DP) processes for human use. There is immense potential to print personalized medicines using 3DP. Many 3DP methods have been reported in the literature for pharmaceutical applications. However, selective laser sintering (SLS) printing has remained least explored for pharmaceutical applications. There...
Paper Details
Title
Selective laser sintering 3D printing – an overview of the technology and pharmaceutical applications
Published Date
May 13, 2020
Volume
46
Issue
6
Pages
869 - 877
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.